-
Genetically engineering T-cell cancer killers for acute lymphoblastic leukemia
Madely Health Headlines Commentary for February 20, 2014 Source: ‘Living drug’ kills leukemia in 88 percent of patients Reference: Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
-
HIV treatment with modified T cells successful in small study
Madely Health Headlines Commentary for May 3, 2012 [display_podcast] Source: Gene Therapy Safe in Decade-Long HIV Study That May Widen Use Reference: Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells